Vincent G. Brichard, Senior Vice President and Head of the Immunotherapeutics Business Unit at GlaxoSmithKline Biologicals Will Give a Keynote Presentation at the Immunotherapeutics Partnering and Deal-making Conference (Jan 30-31, 2012 in San Diego,
Vincent G. Brichard, Senior Vice President and Head of the Immunotherapeutics Business Unit at GlaxoSmithKline Biologicals will give a keynote presentation on the “Development of Active Immunization against Cancer: The Example of MAGE-A3” at the Immunotherapeutics Partnering and Deal-making Conference to be held in San Diego, CA on January 30-31, 2012 by GTC.
View full press release